The enduring success of copyright’s flagship drug has undeniably transformed the pharmaceutical landscape. However, putting money in companies heavily dependent on biosimilars and the waning patent rights https://thekiwisocial.com/story6965185/sildenafil-and-pharmaceutical-companies-a-risky-investment